Continuing Medical Education

Improve provider knowledge.

A unique component included as part of Carevive’s research studies is continuing medical education (CME). Medical education provides the foundation for improving provider knowledge and information regarding the latest evidence-based treatment guidelines in cancer care and symptom management. In addition, Carevive educates providers on the latest clinical evidence for treatment and side effect management, as well as the value of collecting patient-reported outcomes, using frailty assessment tools, and engaging patients in shared decision making.

We also use our learning tools to educate participating providers — oncologists, nurses and research staff — on the components of the study as well as instruct them on how to use our platform and incorporate it into their clinical workflow.

CME is vital to the success of our research by engaging providers on the value of the study to them individually as well as to their patients. This leads to improved quality of care and patient outcomes.

CME

Clinically Integrating Patient-Reported Outcomes into Triple-Negative Breast Cancer (TNBC) Care to Improve Symptom Management

Release Date: 3/4/2020 Expiration Date: 3/3/2021 Estimated Time to Complete the Activity: 45 minutes Physicians – Maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses – 0.7 contact hours (0.4 pharmacotherapy) The goals of this initiative are to (1) close existing cancer clinician competency gaps regarding newly approved and emerging therapies for Triple-Negative Breast Cancer TNBC and the management…
Carevive
March 4, 2020
CME

Clinically Integrating Patient-Reported Outcomes into Acute Myeloid Leukemia Care Management

Release Date: 11/8/2019 Expiration Date: 11/9/2020 Physicians – Maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses – 1.2 contact hours (0.4 pharmacotherapy) The goal of this project is to identify the variety of symptoms relevant to patients receiving treatment for AML and test the electronic Patient Reported Outcomes (ePRO) tool in the clinical setting. A certified educational training…
Carevive
November 27, 2019
CME

Applying the Shared Decision-Making Model to Inform Treatment Decision Making in Multiple Myeloma (MM)

Release Date: 9/23/2019 Expiration Date: 9/22/2020 Physicians – Maximum of 1.5 AMA PRA Category 1 Credits™ Registered Nurses – 1.4 contact hours (0.4 pharmacotherapy) The goal of this project is to evaluate the effectiveness of a shared decision-making (SDM) model in advancing care outcomes as well as clinician and patient engagement in managing multiple myeloma (MM). We will evaluate the…
Carevive
September 23, 2019
CME

Multiple Myeloma in 2019: Maintenance Therapy & Treatment Side Effect Management

Release Date: 6/7/2019 Expiration Date: 6/6/2020 Physicians – Maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses – 0.6 contact hours (0.3 pharmacotherapy) Target Audience The target audience for this activity is U.S.-based hematologists/oncologists, hematology/oncology NPs/PAs, and registered nurses. Faculty Rafael Fonseca, MD, FACP Mayo Clinic – Arizona Beth Faiman, PhD, APRN-BC, AOCN Cleveland Clinic Educational Objectives After completing this activity, the participant should be…
Carevive
June 18, 2019
CME

Multiple Myeloma in 2019: Updates and Clinical Trial Data

Release Date: 6/7/2019 Expiration Date: 6/6/2020 Physicians – Maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses – 0.6 contact hours (0.3 pharmacotherapy) Target Audience The target audience for this activity is U.S.-based hematologists/oncologists, hematology/oncology NPs/PAs, and registered nurses. Faculty Rafael Fonseca, MD, FACP Mayo Clinic – Arizona Educational Objectives After completing this activity, the participant should be better able to: Consider clinical trial data…
Carevive
June 18, 2019
CME

Multiple Myeloma in 2019: The Geriatric Assessment Tool and Clinical Evidence

Release Date: 6/7/2019 Expiration Date: 6/6/2020 Physicians – Maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses – 0.5 contact hours Target Audience The target audience for this activity is U.S.-based hematologists/oncologists, hematology/oncology NPs/PAs, and registered nurses. Faculty Tanya Wildes, MD, MSCI Washington University School of Medicine Educational Objectives After completing this activity, the participant should be better able to: Consider real-world evidence when managing…
Carevive
June 7, 2019
CME

Clinically Integrating Patient-Reported Outcomes into Metastatic Colorectal Care Management

Release date: May 22, 2019 
Expiration date: May 21, 2020 Physicians – Maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses – 0.5 contact hours (0.2 pharmacotherapy) Target Audience The target audience for this activity a U.S.-based medical oncologists, oncology Advanced Practice Providers, oncology nurses and nurse navigators. Educational Objectives After completing this activity, the participant should be better able…
Carevive
May 30, 2019
CME

Applying a Shared Decision-Making Framework for Treatment Planning in DLBCL and FL

Release date: May 22, 2019 
Expiration date: May 21, 2020 Physicians – Maximum of 1.0 AMA PRA Category 1 Credits™ Registered Nurses – 1.0 contact hours (0.7 pharmacotherapy) Target Audience The target audience for this activity is U.S.-based hematologists/oncologists, advanced practice nurses, physician assistants, oncology nurses, nurse navigators, and cancer center administrators caring for patients with non-Hodgkin lymphoma. Educational Objectives After completing…
Carevive
May 22, 2019
CME

Evolving Evidence-Based Treatment Paradigms for Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

Release date: April 15, 2019 
Expiration date: April 14, 2020 Estimated time to complete activity: 45 minutes In 2018, there will be an estimated 164,690 new cases of prostate cancer (PC) in the U.S. and approximately 29,430 patients will die of the disease, making it the third-leading cause of cancer death in men (American Cancer Society , 2018). The majority…
Carevive
April 15, 2019
CME

What’s New in Acute Myelogenous Leukemia?

Release date: October 17, 2018 
Expiration date: October 16, 2019 Estimated time to complete activity: 0.75 hours Acute myelogenous leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit…
Carevive
October 17, 2018
CME

Geriatric Assessment in Older Patients with AML: Treatment Updates and Implications

Release date: October 17, 2018 
Expiration date: October 16, 2019 Estimated time to complete activity: 0.5 hours Acute myelogenous leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit…
Carevive
October 17, 2018
CME

Defining What is Value-Based Care for Patients with ​Relapsed/Refractory Chronic Lymphocytic Leukemia​

Defining What is Value-Based Care for Patients with ​Relapsed/Refractory Chronic Lymphocytic Leukemia​​ Release Date: July 6, 2018 Expiration Date:July 6, 2019 ESTIMATED TIME TO COMPLETE ACTIVITY: 150 minutes (2.5 hours)​     TARGET AUDIENCE The target audiences for these activities are hematologists, medical oncologists, pulmonologists, pathologists, physician assistants, nurse practitioners, registered nurses, oncology nurses, nurse navigators, palliative/symptom management teams who care for…
Carevive
July 6, 2018
CMEEvents

[Webinar] Defining What is Value-Based Care for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Defining What is Value-Based Care for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: An Expert Roundtable Discussion Saturday, November 4, 2017 8:30 am – 12:05 pm CST UAB Comprehensive Cancer Center Birmingham, Alabama Do the requirements of OCM and other value-based cancer delivery models leave you overwhelmed about where and how to start? If so, then join us for a CME/CNE-Certified…
Carevive
October 17, 2017
CME

Evidence-Based Clinical Updates in the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Evidence-Based Clinical Updates in the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia       For information about AMA PRA Category 2 CreditTM, you may consult page 10 of the AMA’s booklet “The Physicians Recognition Award and credit system: Information for accredited providers and physicians – 2010 Revision” found here. The aim of the project is to ensure hematology…
Carevive
June 14, 2017
CME

Evidence-Based Clinical Practices on Shared Decision Making in Metastatic Breast Cancer

Evidence-Based Clinical Practices on Shared Decision Making in Metastatic Breast Cancer Release Date: May 1, 2017  Expiration Date: April 30, 2018 ESTIMATED TIME TO COMPLETE ACTIVITY: 1.5 hours Oncology experts provide current evidence based treatment guidelines and updates on emerging therapies for care of women with metastatic breast cancer (MBC). This CME activity is for medical oncologists, pathologists, physician assistants, nurse practitioners, oncology nurses,…
Carevive
May 11, 2017
CME

Emerging Therapies & Clinical Trial Opportunities for ER-Positive, HER2 Negative Metastatic Breast Cancer and HER2-Positive Breast Cancer

Emerging Therapies & Clinical Trial Opportunities for ER-Positive, HER2 Negative Metastatic Breast Cancer and HER2-Positive Breast Cancer Release Date: November 21, 2016  Expiration Date: November 20, 2017 ESTIMATED TIME TO COMPLETE ACTIVITY: 1.5 hours (0.5 per module)         TARGET AUDIENCE The target audience for these activities includes community- based medical oncologists, physician assistants, nurse practitioners, clinical nurse specialists, oncology…
Carevive
December 2, 2016
CMEEvents

Carevive Advanced NSCLC Oncology Care Model Symposium at Jefferson University

The Oncology Care Model: Integrating the 13 Point IOM Care Management Plan for Patients With Advanced NSCLC Wednesday, October 26, 2016 8 am – 12 noon Solis Cohen Auditorium Thomas Jefferson University Hospital Philadelphia, PA 13 point care management plans ... 12 Key Performance Indicators... Improving navigation, care coordination, & guideline-adherent care... Reducing ED visits and hospitalizations and improving palliative care…
Carevive
August 24, 2016
CME

Integrating Frailty Screening for Older Patients Diagnosed with Multiple Myeloma

Integrating Frailty Screening for Older Patients Diagnosed with Multiple Myeloma Release Date: February 29, 2016  Expiration Date: December 31, 2017 ESTIMATED TIME TO COMPLETE ACTIVITY: 1 hour This activity is supported by an independent educational grant from Celgene Pharmaceuticals, and Takeda Oncology.     TARGET AUDIENCE This activity has been designed to meet the educational needs of hematologists, medical oncologists, physician assistants, nurse…
Carevive
March 2, 2016
CME

Achievement of National Quality Standards in HER2-positive Breast Cancer

Achievement of National Quality Standards in HER2-positive Breast Cancer: A Pilot Study on the Impact of Certified Education Plus a Novel Care Planning Tool FOR REFERENCE ONLY Release Date: July 27, 2015  Expiration Date: July 27, 2016 ESTIMATED TIME TO COMPLETE ACTIVITY: 1.75 hours Jointly provided by Postgraduate Institute for Medicine and Carevive Systems, Inc. (formerly On Q Health)     TARGET AUDIENCE The…
Carevive
January 8, 2016
CME

Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning

Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning Release Date: July 24, 2015  Expiration Date: March 24, 2017 ESTIMATED TIME TO COMPLETE ACTIVITY: 1.5 hours Jointly provided by Postgraduate Institute for Medicine and Carevive Systems, Inc. (formerly On Q Health)     TARGET AUDIENCE The target audiences for these activities are surgeons, surgical oncologists, medical…
Carevive
January 7, 2016
CME

Integrating Routine Nutritional Screenings for Cancer Patients at the Point of Care

Integrating Routine Nutritional Screenings for Cancer Patients at the Point of Care: Pilot Testing a Novel Care Planning System Plus Certified Professional Training FOR REFERENCE ONLY Release Date: November 13, 2015  Expiration Date: November 13, 2016 ESTIMATED TIME TO COMPLETE ACTIVITY: 1.25 hours Jointly provided by Postgraduate Institute for Medicine and Carevive Systems, Inc. (formerly On Q Health)     TARGET AUDIENCE The target audience for these activities…
Carevive
November 30, 2015
CME

Improving Clinical Trial Awareness in NSCLC

Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care FOR REFERENCE ONLY Release Date: March 23, 2015  Expiration Date: March 24, 2016 ESTIMATED TIME TO COMPLETE ACTIVITY: 3.75 hours Jointly provided by Postgraduate Institute for Medicine and Carevive Systems, Inc. (formerly On Q Health)     TARGET AUDIENCE This activity has…
Carevive
August 26, 2015
CME

Improving the Quality of Multiple Myeloma Treatment with Patient Care Plans

Improving the Quality of Multiple Myeloma Treatment with Patient Care Plans: Pilot Testing the Impact of Continuing Education and Care Planning on Symptom Management FOR REFERENCE ONLY Release Date: April 24, 2015        Valid for credit through December 31, 2016 ESTIMATED TIME TO COMPLETE ACTIVITY: 4.75 hours Jointly provided by Postgraduate Institute for Medicine and Carevive Systems, Inc.   TARGET AUDIENCE This…
Carevive
June 1, 2015